Skip to main content
Erschienen in: European Radiology 1/2009

01.01.2009 | Pediatric

Pediatric liver tumors – a pictorial review

verfasst von: Priyanka Jha, Soni C. Chawla, Sidhartha Tavri, Chirag Patel, Charles Gooding, Heike Daldrup-Link

Erschienen in: European Radiology | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Hepatic masses constitute about 5–6% of all intra-abdominal masses in children. The majority of liver tumors in children are malignant; these malignant liver tumors constitute the third most common intra-abdominal malignancy in the pediatric age group after Wilms’ tumor and neuroblastoma. Only about one third of the liver tumors are benign. A differential diagnosis of liver tumors in children can be obtained based on the age of the child, clinical information (in particular AFP) and imaging characteristics. The purpose of this review is to report typical clinical and imaging characteristics of benign and malignant primary liver tumors in children.
Literatur
1.
Zurück zum Zitat Kuhn JP, Slovis TL, Haller JO, Caffey J (eds) (2004) Caffey’s pediatric diagnostic imaging, 10th edn. Mosby, Philadelphia Kuhn JP, Slovis TL, Haller JO, Caffey J (eds) (2004) Caffey’s pediatric diagnostic imaging, 10th edn. Mosby, Philadelphia
2.
Zurück zum Zitat Helmberger TK, Ros PR, Mergo PJ et al (1999) Pediatric liver neoplasms: a radiologic-pathologic correlation. Eur Radiol 9:1339–1347PubMedCrossRef Helmberger TK, Ros PR, Mergo PJ et al (1999) Pediatric liver neoplasms: a radiologic-pathologic correlation. Eur Radiol 9:1339–1347PubMedCrossRef
4.
Zurück zum Zitat Szymik-Kantorowicz S, Partyka L, Dembinska-Kiec A et al (2003) Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma. Med Pediatr Oncol 40:196–197PubMedCrossRef Szymik-Kantorowicz S, Partyka L, Dembinska-Kiec A et al (2003) Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma. Med Pediatr Oncol 40:196–197PubMedCrossRef
5.
Zurück zum Zitat Ayling RM, Davenport M, Hadzic N et al (2001) Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor. J Pediatr 138:932–935PubMedCrossRef Ayling RM, Davenport M, Hadzic N et al (2001) Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor. J Pediatr 138:932–935PubMedCrossRef
6.
Zurück zum Zitat Schneider G, Grazioli L, Saini S (eds) (2003) MRI of the liver: imaging techniques, contrast enhancement, differential diagnosis. Springer, Milan, New York, p 214 Schneider G, Grazioli L, Saini S (eds) (2003) MRI of the liver: imaging techniques, contrast enhancement, differential diagnosis. Springer, Milan, New York, p 214
7.
Zurück zum Zitat Stringer MD, Alizai NK (2005) Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg 40:1681–1690PubMedCrossRef Stringer MD, Alizai NK (2005) Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg 40:1681–1690PubMedCrossRef
8.
Zurück zum Zitat Chang HJ, Jin SY, Park C et al (2006) Mesenchymal hamartomas of the liver: comparison of clinicopathologic features between cystic and solid forms. J Korean Med Sci 21:63–68PubMedCrossRef Chang HJ, Jin SY, Park C et al (2006) Mesenchymal hamartomas of the liver: comparison of clinicopathologic features between cystic and solid forms. J Korean Med Sci 21:63–68PubMedCrossRef
9.
Zurück zum Zitat Bartolotta TV, Midiri M, Galia M et al (2001) Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media. Radiol Med (Torino) 101:219–229 Bartolotta TV, Midiri M, Galia M et al (2001) Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media. Radiol Med (Torino) 101:219–229
10.
Zurück zum Zitat Beets-Tan RG, Van Engelshoven JM, Greve JW (1998) Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI. Clin Imaging 22:211–215PubMedCrossRef Beets-Tan RG, Van Engelshoven JM, Greve JW (1998) Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI. Clin Imaging 22:211–215PubMedCrossRef
11.
Zurück zum Zitat Kim MJ, Kim JH, Lim JS et al (2004) Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 20:612–621PubMedCrossRef Kim MJ, Kim JH, Lim JS et al (2004) Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 20:612–621PubMedCrossRef
12.
Zurück zum Zitat Mergo PJ, Engelken JD, Helmberger T et al (1998) MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents. J Magn Reson Imaging 8:1073–1078 Mergo PJ, Engelken JD, Helmberger T et al (1998) MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents. J Magn Reson Imaging 8:1073–1078
13.
Zurück zum Zitat Urhahn R, Adam G, Busch N et al (1996) Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions? Rofo 165:364–370PubMed Urhahn R, Adam G, Busch N et al (1996) Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions? Rofo 165:364–370PubMed
14.
Zurück zum Zitat Pena CS, Saini S, Baron RL et al (2001) Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial. Korean J Radiol 2:210–215PubMedCrossRef Pena CS, Saini S, Baron RL et al (2001) Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial. Korean J Radiol 2:210–215PubMedCrossRef
15.
Zurück zum Zitat Frohlich JM (2004) MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. J Magn Reson Imaging 19:375–376 author reply 376PubMedCrossRef Frohlich JM (2004) MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. J Magn Reson Imaging 19:375–376 author reply 376PubMedCrossRef
16.
Zurück zum Zitat Grazioli L, Morana G, Kirchin MA et al (2003) MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. J Magn Reson Imaging 17:593–602PubMedCrossRef Grazioli L, Morana G, Kirchin MA et al (2003) MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. J Magn Reson Imaging 17:593–602PubMedCrossRef
17.
Zurück zum Zitat Maruyama K, Ikeda H, Koizumi T et al (2000) Case-control study of perinatal factors and hepatoblastoma in children with an extremely low birthweight. Pediatr Int 42:492–498PubMedCrossRef Maruyama K, Ikeda H, Koizumi T et al (2000) Case-control study of perinatal factors and hepatoblastoma in children with an extremely low birthweight. Pediatr Int 42:492–498PubMedCrossRef
18.
Zurück zum Zitat Tanimoto A, Kuwatsuru R, Kadoya M et al (1999) Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: results from phase II and phase III clinical trials in Japan. J Magn Reson Imaging 10:450–460PubMedCrossRef Tanimoto A, Kuwatsuru R, Kadoya M et al (1999) Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: results from phase II and phase III clinical trials in Japan. J Magn Reson Imaging 10:450–460PubMedCrossRef
19.
Zurück zum Zitat Hamm B, Kirchin M, Pirovano G et al (1999) Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA. J Comput Assist Tomogr 23(Suppl 1):S53–S60PubMed Hamm B, Kirchin M, Pirovano G et al (1999) Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA. J Comput Assist Tomogr 23(Suppl 1):S53–S60PubMed
20.
Zurück zum Zitat Lauwers GY, Grant LD, Donnelly WH et al (1997) Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol 21:1248–1254PubMedCrossRef Lauwers GY, Grant LD, Donnelly WH et al (1997) Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol 21:1248–1254PubMedCrossRef
21.
Zurück zum Zitat O'Sullivan MJ, Swanson PE, Knoll J et al (2001) Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr Dev Pathol 4:482–489PubMedCrossRef O'Sullivan MJ, Swanson PE, Knoll J et al (2001) Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr Dev Pathol 4:482–489PubMedCrossRef
22.
Zurück zum Zitat Ramanujam TM, Ramesh JC, Goh DW et al (1999) Malignant transformation of mesenchymal hamartoma of the liver: case report and review of the literature. J Pediatr Surg 34:1684–1686PubMedCrossRef Ramanujam TM, Ramesh JC, Goh DW et al (1999) Malignant transformation of mesenchymal hamartoma of the liver: case report and review of the literature. J Pediatr Surg 34:1684–1686PubMedCrossRef
23.
Zurück zum Zitat Craig JR (1994) Mesenchymal tumors of the liver. Diagnostic problems for the surgical pathologist. Pathology (Phila) 3:141–160 Craig JR (1994) Mesenchymal tumors of the liver. Diagnostic problems for the surgical pathologist. Pathology (Phila) 3:141–160
24.
Zurück zum Zitat Boechat MI, Kangarloo H (1989) MR imaging of the abdomen in children. AJR Am J Roentgenol 152:1245–1250PubMed Boechat MI, Kangarloo H (1989) MR imaging of the abdomen in children. AJR Am J Roentgenol 152:1245–1250PubMed
25.
Zurück zum Zitat White KS (1996) Reduced need for sedation in patients undergoing helical CT of the chest and abdomen. Pediatr Radiol 26:5PubMedCrossRef White KS (1996) Reduced need for sedation in patients undergoing helical CT of the chest and abdomen. Pediatr Radiol 26:5PubMedCrossRef
26.
Zurück zum Zitat Paterson A, Frush DP, Donnelly LF (2001) Helical CT of the body: are settings adjusted for pediatric patients? AJR Am J Roentgenol 176:297–301PubMed Paterson A, Frush DP, Donnelly LF (2001) Helical CT of the body: are settings adjusted for pediatric patients? AJR Am J Roentgenol 176:297–301PubMed
27.
Zurück zum Zitat Frush DP, Slack CC, Hollingsworth CL et al (2002) Computer-simulated radiation dose reduction for abdominal multidetector CT of pediatric patients. AJR Am J Roentgenol 179:1107–1113PubMed Frush DP, Slack CC, Hollingsworth CL et al (2002) Computer-simulated radiation dose reduction for abdominal multidetector CT of pediatric patients. AJR Am J Roentgenol 179:1107–1113PubMed
28.
Zurück zum Zitat Slovis TL (2003) Children, computed tomography radiation dose, and the As Low As Reasonably Achievable (ALARA) concept. Pediatrics 112:971–972PubMedCrossRef Slovis TL (2003) Children, computed tomography radiation dose, and the As Low As Reasonably Achievable (ALARA) concept. Pediatrics 112:971–972PubMedCrossRef
29.
Zurück zum Zitat da Costa e Silva EJ, da Silva GA (2007) Eliminating unenhanced CT when evaluating abdominal neoplasms in children. AJR Am J Roentgenol 189:1211–1214PubMedCrossRef da Costa e Silva EJ, da Silva GA (2007) Eliminating unenhanced CT when evaluating abdominal neoplasms in children. AJR Am J Roentgenol 189:1211–1214PubMedCrossRef
30.
Zurück zum Zitat Frush DP, Donnelly LF (1998) Helical CT in children: technical considerations and body applications. Radiology 209:37–48PubMed Frush DP, Donnelly LF (1998) Helical CT in children: technical considerations and body applications. Radiology 209:37–48PubMed
31.
Zurück zum Zitat Vade A, Demos TC, Olson MC et al (1996) Evaluation of image quality using 1:1 pitch and 1.5:1 pitch helical CT in children: a comparative study. Pediatr Radiol 26:891PubMedCrossRef Vade A, Demos TC, Olson MC et al (1996) Evaluation of image quality using 1:1 pitch and 1.5:1 pitch helical CT in children: a comparative study. Pediatr Radiol 26:891PubMedCrossRef
32.
Zurück zum Zitat Vade A, Olson MC, Vittore CP et al (1999) Hepatic enhancement analysis in children using Smart Prep monitoring for 2:1 pitch helical scanning. Pediatr Radiol 29:689–693PubMedCrossRef Vade A, Olson MC, Vittore CP et al (1999) Hepatic enhancement analysis in children using Smart Prep monitoring for 2:1 pitch helical scanning. Pediatr Radiol 29:689–693PubMedCrossRef
33.
Zurück zum Zitat Roche KJ, Genieser NB, Ambrosino MM (1996) Pediatric hepatic CT: An injection protocol. Pediatr Radiol 26:502–507PubMedCrossRef Roche KJ, Genieser NB, Ambrosino MM (1996) Pediatric hepatic CT: An injection protocol. Pediatr Radiol 26:502–507PubMedCrossRef
34.
Zurück zum Zitat Ruess L, Bulas DI, Kushner DC et al (1998) Peak enhancement of the liver in children using power injection and helical CT. AJR Am J Roentgenol 170:677–681PubMed Ruess L, Bulas DI, Kushner DC et al (1998) Peak enhancement of the liver in children using power injection and helical CT. AJR Am J Roentgenol 170:677–681PubMed
35.
Zurück zum Zitat Haliloglu M, Hoffer FA, Gronemeyer SA et al (2000) Three dimensional gadolinium-enhanced MR angiography evaluation of hepatic vasculature in children with hepatoblastoma. J Magn Reson Imaging 11 Haliloglu M, Hoffer FA, Gronemeyer SA et al (2000) Three dimensional gadolinium-enhanced MR angiography evaluation of hepatic vasculature in children with hepatoblastoma. J Magn Reson Imaging 11
36.
Zurück zum Zitat Teo EHJ, Strouse PJ, Prince MR (1999) Applications of magnetic resonance imaging and magnetic resonance angiography to evaluatge the hepatic vasculature in the pediatric patient. Pediatr Radiol 29:238–243PubMedCrossRef Teo EHJ, Strouse PJ, Prince MR (1999) Applications of magnetic resonance imaging and magnetic resonance angiography to evaluatge the hepatic vasculature in the pediatric patient. Pediatr Radiol 29:238–243PubMedCrossRef
37.
Zurück zum Zitat Rawsin JV, Seigel MJ (1996) Techniques and strategies in pediatric body MR imaging. Magn Reson Imaging Clin North Am 4:589–598 Rawsin JV, Seigel MJ (1996) Techniques and strategies in pediatric body MR imaging. Magn Reson Imaging Clin North Am 4:589–598
38.
Zurück zum Zitat Gillies RJ, Morse DL (2005) In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng 7:287–326PubMedCrossRef Gillies RJ, Morse DL (2005) In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng 7:287–326PubMedCrossRef
39.
Zurück zum Zitat Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19:598–604PubMedCrossRef Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19:598–604PubMedCrossRef
40.
Zurück zum Zitat Li CW, Kuo YC, Chen CY et al (2005) Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T. Magn Reson Med 53:770–776PubMedCrossRef Li CW, Kuo YC, Chen CY et al (2005) Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T. Magn Reson Med 53:770–776PubMedCrossRef
41.
Zurück zum Zitat Weiner MW, Hetherington H, Hubesch B et al (1989) Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. NMR Biomed 2:290–297PubMedCrossRef Weiner MW, Hetherington H, Hubesch B et al (1989) Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. NMR Biomed 2:290–297PubMedCrossRef
42.
Zurück zum Zitat Bell JD, Bhakoo KK (1998) Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours. NMR Biomed 11:354–359PubMedCrossRef Bell JD, Bhakoo KK (1998) Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours. NMR Biomed 11:354–359PubMedCrossRef
Metadaten
Titel
Pediatric liver tumors – a pictorial review
verfasst von
Priyanka Jha
Soni C. Chawla
Sidhartha Tavri
Chirag Patel
Charles Gooding
Heike Daldrup-Link
Publikationsdatum
01.01.2009
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 1/2009
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-008-1106-7

Weitere Artikel der Ausgabe 1/2009

European Radiology 1/2009 Zur Ausgabe

Ultrasound

Ultrasound

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.